Agenda

Speakers23 Speakers

Jonathan Banchs
Jonathan Banchs

Director of Content and Experience

MOMENTUM EVENTS
Eleni Allen
Eleni Allen

Director, REMS Strategy and Execution

GSK
Deborah Collyar
Deborah Collyar

President

Patient Advocates In Research
Michele Davidson
Michele Davidson

Senior Manager, Pharmacy Technical Standards, Development and Policy

WALGREENS
Nancy Dubois
Nancy Dubois

Associate Director, Local Safety Officer US Region

Alexion Pharmaceuticals
Bertha Ferrer
Bertha Ferrer

Senior Director, Head of Quality Management and Inspections

PFIZER
Jackie Gerena
Jackie Gerena

Director, Program Management (REMS Program)

Aimmune Therapeutics
Kishore Gopu
Kishore Gopu

Senior Director, REMS Operations

Teva Pharmaceuticals USA
Kyle Irwin
Kyle Irwin

Operations Lead, REMS and Risk Management Center

Johnson & Johnson
Madalo Maliro
Madalo Maliro

Senior Manager, REMS Program

Aimmune Therapeutics
Suzanne Marinello
Suzanne Marinello

Associate Director REMS and Patient Support

FORMER OTSUKA AMERICA
Sherry Mills
Sherry Mills

Executive Director, Risk Management U.S.& Canada

Jazz Pharmaceuticals
Owen Muir
Owen Muir

Ceo

Sphere Health
Jaylaxmi Nalawade
Jaylaxmi Nalawade

Associate Director - Pharmacovigilance and REMS

Lupin Inc.
Catina O’Leary
Catina O’Leary

President & CEO

HEALTH LITERACY MEDIA
Chantal Phillips
Chantal Phillips

Former Risk Evaluation and Mitigation Strategies (REMS) Coordinator Team Lead

FORMER FDA
Jennifer Reinert
Jennifer Reinert

Director, Risk Management Product Lead, Worldwide Safety and Regulatory

PFIZER
Sheline Way
Sheline Way

Senior Manager, REMS Operations

Teva Pharmaceuticals USA
Jamie Wilkins
Jamie Wilkins

Head- Risk Management Center of Excellence- Worldwide Safety

PFIZER
Anupam Agarwal
Anupam Agarwal

Vice President and Head of Drug Safety & Pharmacovigilance

Zogenix
Carlene Macmillan
Carlene Macmillan

Medical Director, Product and Growth

OSMIND
Jimmy Qian
Jimmy Qian

Co-founder & Chief Operating Officer

Osmind
Kal Elhoregy
Kal Elhoregy

Risk Evaluation and Mitigation Strategy (REMS) Programs

AMNEAL PHARMACEUTICALS